Codrituzumab-MMAE Biosimilar (GPC3 / Glypican-3 Reference Antibody)
Codrituzumab-MMAE, is an antibody-drug conjugate composed of a anti-GPC3 monoclonal antibody and a cytotoxic tubulin polymerase inhibitor conjugated through MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) type linker.
Product Specifications
Target
Codrituzumab-MMAE Biosimilar (Anti-GPC3 / Glypican-3 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog